Pharma stocks tank up to 6% amid fears of US tariffs on drug imports

Indian pharma stocks extended their losing streak to the third consecutive trading session on Thursday, March 27, as concerns grew that US President Donald Trump may announce tariffs on pharmaceutical imports, following his imposition of duties on automobiles. Among individual performers, J B Chemicals & Pharmaceuticals shares emerged as the top laggards, dropping 6%. Ajanta Pharma, Granules India, and Sun Pharmaceutical also traded with losses, ranging between 2% and 4%.